from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3053c/nrdH

LFCtreatmentdescriptionclass of inhibitor

1.574

Amikacinug/mL Amikacintranslation

0.525

Cap5-10ug/mL Capreomycintranslation

0.830

Rox10-50 ug/mL Roxithromycintranslation

0.337

SM2-5 ug/mL Streptomycintranslation

1.613

Tet5-10 ug/mL Tetracyclinetranslation

-2.067

Rif0.2-5ug/mL Rifampicintranscription

-1.427

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.048

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.390

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.191

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.549

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.714

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.990

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.285

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.361

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.604

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.483

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.289

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.486

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.922

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.480

KCN5-20 ug/mL Potassium cyaniderespiration

-0.257

NaN30.2-2 mM Sodium aziderespiration

0.319

Nigericin50 uM Nigericinrespiration

0.609

TRC10-150 ug/mL Triclosanrespiration

0.457

TRZ10-25 ug/mL Thioridazinerespiration

-0.241

Valinomycin0.5-10 uM Valinomycinrespiration

-0.501

ZnSO42 mM ZnSO4respiration

2.610

menadione6-10 ug/mL Menadionerespiration

-0.811

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.798

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.974

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.443

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.697

NRP_1Non-replicating persistence stage 1dosRassociated

-0.222

Amp0.2mg/mL AmpicillincellWall

-0.314

Cephalexin20-100 ug/mL CephalexincellWall

-0.334

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.221

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.524

EMB10-20 ug/mL EthambutolcellWall

0.329

Eta12-40 ug/mL EthionamidecellWall

0.276

INH0.2-0.4 ug/mL IsoniazidcellWall

0.149

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.685

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.100

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.052

BZA0.12 mg/mL BenzamidearomaticAmides

0.672

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.715

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.483

H2O24 mM hydrogen peroxideDNAdamaging

0.744

Levo10 ug/mL LevofloxacinDNAdamaging

-0.425

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.358

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.220

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.116

UVUV-irradiationDNAdamaging

3.145

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.863

Antimycin12.5-50 ug/mL Antimycin A?

-0.674

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.622

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.924

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.044

PA8240.2-2 ug/mL PA-824?

0.737

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.270

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.192

Verapamil50 uM Verapamil?

-0.405

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.156

methoxatin10-20 ug/mL Methoxatin?